The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2018 | The recording and referral of smokers in the UK: an area for improvement
Tobacco use is a major determinant of lung cancer risk; therefore, it is vital that a patient’s smoking status and history is recorded, and that active smokers are referred to improve smoking cessation rates. Speaking from the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland, Sanjay Agrawal, MBBS, of the University Hospitals of Leicester NHS Trust, Leicester, UK, discusses the importance of this issue.
